Bedside diagnostic testing of body fluids.
Numerous bedside diagnostic modalities are appropriate for the practice of emergency medicine. The proliferation of sophisticated technology is likely to increase both the availability and accuracy of commercial testing products. If health care reform in the United States results in a relaxation of the CLIA regulations, there will be a rapid expansion of research and development aimed at the biotechnology market. How much this would pertain to hospital-based emergency practice remains to be seen. Cost containment pressures may act in both directions on the utilization of available bedside technology. Although these tests are often less expensive than centralized laboratory determinations, the ready availability of near-patient testing may result in an increase in use that negates the lower cost. As with other diagnostic modalities, a thoughtful, considered approach based on scientific evidence will be necessary to formulate the appropriate use of bedside testing in individual emergency practice settings.
Peredy
T R
TR
Division of Emergency Medicine, University of Connecticut School of Medicine, Hartford, USA.
Powers
R D
RD
D000653:Amniotic Fluid / Q000737:chemistry; D001826:Body Fluids / Q000737:chemistry*; D001944:Breath Tests; D000431:Ethanol / Q000032:analysis / Q000097:blood; D005260:Female; D006471:Gastrointestinal Hemorrhage / Q000097:blood; D006801:Humans; D007158:Immunologic Techniques; D007239:Infections / Q000276:immunology; D008297:Male; D009780:Occult Blood; D011247:Pregnancy; D011258:Pregnancy Tests; D011934:Reagent Strips; D015813:Substance Abuse Detection; D014556:Urine / Q000737:chemistry
D011934:Reagent Strips; D000431:Ethanol